Steven Blotner
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Hepatology top 5%
- Hepatitis C virus research
Papers in
- Oncology 12
- Cancer-related Molecular Pathways 7
- HER2/EGFR in Cancer Research 3
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Vaikunth Cuchelkar (2 shared papers)Katja Schulze (2 shared papers)Funda Meric‐Bernstam (2 shared papers)Howard A. Burris (2 shared papers)Ron Bose (2 shared papers)John D. Hainsworth (2 shared papers)David R. Spigel (2 shared papers)Christopher J. Sweeney (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Investigational New Drugs (3 papers)Journal of Hepatology (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Steven Blotner
36 papers receiving 1.1k citations
Steven Blotner's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 508
- Hepatology 134
- Cancer Research 145
- Hematology 98
- Pathology and Forensic Medicine 129
Countries citing papers authored by Steven Blotner
This map shows the geographic impact of Steven Blotner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Blotner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Blotner more than expected).
Fields of papers citing papers by Steven Blotner
This network shows the impact of papers produced by Steven Blotner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Blotner. The network helps show where Steven Blotner may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Blotner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study Hit paper breakdown → | 2019 | 387 |
| 2 | 2020 | 82 | |
| 3 | 1993 | 74 | |
| 4 | 2006 | 61 | |
| 5 | 2014 | 58 | |
| 6 | Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. | 1996 | 53 |
| 7 | 2014 | 45 | |
| 8 | 2016 | 40 | |
| 9 | 2013 | 34 | |
| 10 | 2006 | 34 | |
| 11 | 2021 | 28 | |
| 12 | 2000 | 22 | |
| 13 | 2013 | 20 | |
| 14 | 2001 | 19 | |
| 15 | 2013 | 18 | |
| 16 | 2020 | 16 | |
| 17 | 2012 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2018 | 16 | |
| 20 | 2019 | 14 |
About Steven Blotner
Steven Blotner is a scholar working on Oncology, Infectious Diseases, Ophthalmology, Molecular Biology and Hematology, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Cancer-related Molecular Pathways (7 papers), Retinal Diseases and Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers), Hepatitis C virus research (4 papers), HER2/EGFR in Cancer Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Oncology (508 citations), Hepatology (134 citations), Cancer Research (145 citations), Hematology (98 citations) and Pathology and Forensic Medicine (129 citations). Steven Blotner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Vaikunth Cuchelkar, Katja Schulze, Funda Meric‐Bernstam, Howard A. Burris, Ron Bose, John D. Hainsworth, David R. Spigel, Christopher J. Sweeney, Charles Swanton and Razelle Kurzrock. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Chemotherapy and Pharmacology, Investigational New Drugs and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.